Discover Our Unique Cartilage Repair Solution

There are now nearly 230 million patients with osteoarthritis in the world and 4 million additional cartilage lesions per year. Osteoarthritis results anatomically in the destruction of cartilage in the joints (knee, hip, etc.), which causes severe pain and a significant reduction in mobility.

ACS Biotech is an innovative biotechnology company created in 2013 by Pascale Hazot, Doctor of Chemistry and MBA from EM Lyon. Specialized in regenerative medicine, ACS Biotech has developed a unique cartilage repair solution based on a 3D matrix of natural biomaterial (Chitosan) and cartilage cells.